Catalyst Wire Dossier Catalyst Wire Dossier

BIRB 1017 BS

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIRB 1017 BS, covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of Single Rising Oral Doses of BIRB 1017 BS as a Solution in PEG 400 / 26% Ethanol Administered to Healthy Male Subjects [Phase 1]

See pricing